67.98 F
New York
September 17, 2019
Home » Healthcare (TRBC)

Healthcare (TRBC)

Reuters - Business

Factbox: Britain’s insulin providers prepare for Brexit fallout

Reuters
Georgina poses for a photograph with her insulin medical supplies in London, Britain September 13, 2019.REUTERS/Simon Dawson LONDON (Reuters) – With Britain sourcing the vast
Reuters - Business

With a backup to the backup, insulin makers say they’re primed for Brexit

Reuters
LONDON (Reuters) – For two men trained as scientists, the bosses of Britain’s major insulin providers have had to become experts in ferry schedules, trucking
Reuters - Business

Factbox: What’s next for OxyContin maker Purdue Pharma

Reuters
(Reuters) – OxyContin maker Purdue Pharma LP filed for bankruptcy protection after reaching a partial deal to resolve more than 2,600 lawsuits alleging it helped
Reuters - Business

OxyContin maker Purdue Pharma files for bankruptcy protection

Reuters
NEW YORK (Reuters) – OxyContin maker Purdue Pharma LP filed for bankruptcy protection in New York Sunday night, succumbing to pressure from more than 2,000
Reuters - Business

Reuters asks judge to release secret Propecia documents

Reuters
SAN FRANCISCO (Reuters) – Reuters asked a U.S. judge on Thursday to unseal documents filed in court regarding potential risks associated with Propecia, Merck &
Reuters - Business

U.S., China grant trade concessions as fresh talks loom

Reuters
WASHINGTON/BEIJING (Reuters) – U.S. President Donald Trump on Wednesday welcomed China’s decision to exempt some U.S. anti-cancer drugs and other goods from its tariffs and
Reuters - Business

U.S., China grant trade concessions ahead of fresh talks

Reuters
WASHINGTON/BEIJING (Reuters) – U.S. President Donald Trump on Wednesday welcomed China’s decision to exempt some U.S. anti-cancer drugs and other goods from its tariffs and
Reuters - Business

Exclusive: Purdue Pharma nears partial opioid settlement, bankruptcy filing – sources

Reuters
NEW YORK (Reuters) – OxyContin maker Purdue Pharma LP is nearing a partial agreement to resolve widespread litigation over its alleged role in fueling the
Reuters - Business

China exempts some U.S. goods from retaliatory tariffs as fresh talks loom

Reuters
BEIJING (Reuters) – China announced exemptions for 16 types of U.S. products from additional retaliatory duties, in a move that comes as trade negotiators from
Reuters - Business

More Americans went without health insurance in 2018; income growth stalled

Reuters
WASHINGTON (Reuters) – The share of Americans without health insurance rose for the first time in a decade last year and U.S. household income barely
Reuters - Business

Novartis CEO promises to speed data integrity disclosures

Reuters
FILE PHOTO: CEO Vas Narasimhan of Swiss drugmaker Novartis addresses the company’s annual news conference in Basel, Switzerland January 30, 2019. REUTERS/Arnd Wiegmann/File Photo ZURICH
Reuters - Business

Roche CEO touts drugs pipeline, rules out M&A just to boost sales

Reuters
BASEL, Switzerland (Reuters) – Swiss drugmaker Roche (ROG.S) sees medicines in its own pipeline driving sales growth over the longer term, Chief Executive Severin Schwan
Reuters - Business

Roche doesn’t need M&A to boost sales, sees growth from own meds: CEO

Reuters
BASEL, Switzerland (Reuters) – Swiss drugmaker Roche (ROG.S) sees sales rising in the longer term from medicines in its own pipeline, Chief Executive Severin Schwan
Reuters - Business

Exclusive: OxyContin maker prepares ‘free-fall’ bankruptcy as settlement talks stall

Reuters
(Reuters) – OxyContin maker Purdue Pharma LP is preparing to seek bankruptcy protection before the end of the month if it does not reach a
Reuters - Business

Roche, Spark again extend $4.3 billion takeover offer

Reuters
FILE PHOTO: The logo of Swiss drugmaker Roche at its headquarters in Basel, Switzerland, February 1, 2018. REUTERS/Arnd Wiegmann/File Photo ZURICH (Reuters) – Roche Holding
Reuters - Business

Purdue Pharma in discussion on $10 billion-$12 billion offer to settle opioid lawsuits: sources

Reuters
(Reuters) – OxyContin maker Purdue Pharma LP and its owners, the Sackler family, are in discussion to settle more than 2,000 opioid lawsuits against the
Reuters - Business

Purdue Pharma in discussion on $10 billion-$12 billion offer to settle opioid claims: sources

Reuters
(Reuters) – OxyContin maker Purdue Pharma and its owners, the Sackler family, is in discussion to settle more than 2,000 lawsuits against the company for
Reuters - Business

J&J liable for $572 million in Oklahoma opioid epidemic trial, shares rise

Reuters
NORMAN, Okla. (Reuters) – An Oklahoma judge on Monday ordered Johnson & Johnson (JNJ.N) to pay $572.1 million to the state for its part in
Reuters - Business

J&J liable for $572 million in Oklahoma opioid epidemic trial, but shares surge

Reuters
NORMAN, Okla. (Reuters) – An Oklahoma judge on Monday found Johnson & Johnson (JNJ.N) liable for fueling an opioid epidemic in the state by deceptively
Reuters - Business

Oklahoma judge finds J&J liable in opioid epidemic, orders $572 million damages

Reuters
(Reuters) – An Oklahoma judge on Monday found Johnson & Johnson (JNJ.N) liable for fueling an opioid epidemic in the state by deceptively marketing painkillers,

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Click whichever is suitable. Accept Read More